Dr. Ahmed Hegazi
Market Analysis of Digestive Diseases market is expected to grow from USD 17.27 billion in 2016 and reach USD 19.79 billion in 2022, growing at a CAGR of 2.3% during the forecast period. Our industry experts anticipate that within the Digestive diseases market, the GIT Anti-inflammatory drug will grow at the fastest CAGR ranging from 1% to .5%, during the forecast period. Based on the geographic regions, our experts anticipate that Europe will be the fastest-growing segment during the forecast period
English 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi